CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 52 enrolled
Drug / intervention
paclitaxel coated balloon catheter (device with drug) +1 morecombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00106587
NCT00106587Phase 2Completed
CompareCT.gov

Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons

University Hospital, Saarland·interventional·Posted Mar 28, 2005·Updated Apr 27, 2023

In Brief

A Phase 2 clinical trial evaluating PTCA and paclitaxel coated balloon catheter (device with drug) for Coronary Restenosis. Completed, enrolled 52 participants across 5 sites.

Detailed Summary

The PACCOCATH ISR study is a randomized, double-blinded German multicenter trial on the efficacy and tolerance of a paclitaxel coated balloon catheter in coronary in-stent restenosis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Restenosis
CountriesGermany
Collaborators--

Timeline

Phase 2CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 28, 2005
Enrollment StartDec 1, 2003
Primary CompletionNov 1, 2006
Study CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 21.3 years ago

Interventions

PTCAdevice

paclitaxel coated balloon catheter (device with drug)combination